Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Anti-IL-4 antibodies from Schering-Plough

Jan. 16, 1998

New PAF antagonists disclosed by Korean investigators

Jan. 15, 1998

Schering-Plough discovers dual NK1/NK2 antagonists from fungal strain

Jan. 15, 1998

Antiallergic efficacy of dual-action compound demonstrated in preclinical models

Jan. 14, 1998

New tachykinin antagonists from Schering-Plough

Jan. 8, 1998

FR-167653 protects against ischemia-reperfusion injury in lung in canine model

Jan. 7, 1998

Effects of TxA2 antagonists on IL-8-induced bronchial hyperresponsiveness

Jan. 7, 1998

Antitussive properties of Chinoin xanthine explored

Jan. 7, 1998

FDA clears new Allegra product; Seldane to be withdrawn

Jan. 7, 1998

New class of orally active bradykinin B2 antagonists presented by Fujisawa

Jan. 2, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...